While GK is normally rate limiting in G6P production and β-cell glucose utilization, our model indicates that glucose transport across the plasma membrane becomes rate limiting among models of obesity-associated diabetes in rodents and human β-cells from donors with T2D. This evidence concerns the gene GK and type 2 diabetes mellitus.